🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,328 results for “Xiyuan Hospital of China Academy of Chinese Medical Sciences” Clear

  1. Rosuvastatin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Infarction, Anterior Cerebral Artery

    approved small molecule active

    1 trial

  2. Rosuvastatin (5mg，10mg，20mg)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Carotid Atherosclerosis

    approved small molecule active

    1 trial

  3. Sabin-IPV and DTaP

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Vaccination

    approved mab active

    1 trial

  4. Sabin-IPV+bOPV+bOPV

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Vaccination

    approved mab completed

    1 trial

  5. Salmeterol/Fluticasone Propionate

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chronic Obstructive Pulmonary Disease (COPD)

    approved small molecule active

    1 trial

  6. Salvianolate injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Angina

    approved small molecule active

    1 trial

  7. Saussurea Involucrata Liquid Tonic

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Postpartum Rheumatism

    approved small molecule active

    1 trial

  8. Selective serotonin reuptake inhibitor (SSRI)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Anxiety Depression

    approved small molecule active

    1 trial

  9. Sevelamer

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Degenerative Heart Valve Disease

    approved small molecule active

    1 trial

  10. Sevoflurane

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Intra-abdominal and Intrapelvic Surgery

    approved small molecule completed

    1 trial

  11. Sevoflurane

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Middle Aged Patients

    approved small molecule completed

    1 trial

  12. Shenfu Injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Myocardial Infarction

    approved small molecule completed

    1 trial

  13. Shenfu Injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Septic Cardiomyopathy

    approved small molecule active

    1 trial

  14. Shenlingcao Oral Liquid

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Carcinoma, Non-Small-Cell Lung

    approved small molecule completed

    1 trial

  15. Shexiang Baoxin pill

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Artery Disease(CAD)

    approved small molecule active

    1 trial

  16. Sirolimus

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Antiphospholipid (aPL)-Positive

    approved small molecule active

    1 trial

  17. Sodium Bicarbonate Ringer's Injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Septic Shock

    approved small molecule active

    1 trial

  18. Songling Xuemaikang Capsules

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hypertension,Essential

    approved small molecule active

    1 trial

  19. Succinylcholine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    the Effect of Succinylcholine on Barrier Pressure

    approved small molecule completed

    1 trial

  20. TPO-RAs

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Primary Immune Thrombocytopenia (ITP)

    approved small molecule active

    1 trial

  21. Tacrolimus sustained-release capsule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Renal Transplant Recipients

    approved small molecule completed

    1 trial

  22. Telbivudine treatment

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chronic Hepatitis B

    approved small molecule completed

    1 trial

  23. Tenofovir Alafenamide fumarate 25mg Oral Tablet

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chronic Hepatitis B

    approved small molecule active

    1 trial

  24. Tenofovir disoproxil fumarate

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chronic Hepatitis B

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources